Three-Year Longitudinal Analysis of Splicing Changes in Myotonic Dystrophy Type 1
Cécilia LégaréiD, Lori PlancoiD, Robert MerrittiD, John E. RipolloneiD, Sarah C. ConneriD, Laura M. Desrochers, Fares Nigim, Marie‐Pier RousseliD, Cynthia GagnoniD, John Douglas ClearyiD, J. Andrew BerglundiD, Élise DuchesneiD
Abstract
Myotonic dystrophy type 1 (DM1) is caused by a CTG expansion in the 3' untranslated region of the DMPK gene that results in the expression of expanded CUG RNA which trap splicing factors resulting in widespread alternative splicing dysregulation. A panel of these splicing events, or splicing index (SI), is currently used to measure splicing dysregulation in DM1 patients. Despite significant interest in splicing, little is known about its progression over time in DM1. The objective of this study was to evaluate the changes in SI over 3 years in a well-phenotyped cohort of DM1 participants and identify factors contributing to these changes. RNA was extracted from vastus lateralis (VL) biopsies of 20 DM1 participants taken 3 years apart and the SI score was measured using targeted RNA sequencing. Baseline SI scores correlated with percent predicted muscle strength of the ankle dorsiflexors, knee extensors and hand grip. On average, SI scores worsened over 3 years, but the progression varied markedly among participants. Adult/juvenile phenotypes and lower baseline SI scores were among the factors associated with higher progression of SI scores over time. These findings emphasize the importance of integrating clinical phenotype and baseline molecular severity when interpreting longitudinal SI change, particularly in the context of clinical trials.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1
Marina Provenzano, Kobe Ikegami, … Melissa A. Hale·Journal of Clinical InvestigationPeer-reviewed·Jan 7, 2025
- RNA mis-splicing in children with myotonic dystrophy is associated with physical function
Julia M. Hartman, Kobe Ikegami, … Melissa A. Hale·bioRxiv·Jul 3, 2024
- Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1
Masamitsu Nishi, Takashi Kimura, … Hiroo Yoshikawa·PLoS ONEPeer-reviewed·May 14, 2020
- Analysis of splicing abnormalities in the white matter of myotonic dystrophy type 1 brain using RNA-sequence
Kazuki Yoshizumi, Masamitsu Nishi, … Takashi Kimura·bioRxiv·Dec 23, 2022
- A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients
Max J. F. Degener, Remco T. P. van Cruchten, … Peter A.C. ’t Hoen·NAR Genomics and BioinformaticsPeer-reviewed·Jan 13, 2022
- Transcriptome Alterations in Myotonic Dystrophy Frontal Cortex
Brittney A. Otero, Kiril Poukalov, … Eric T. Wang·Cell ReportsPeer-reviewed·Jan 1, 2021